2271 related articles for article (PubMed ID: 2824550)
21. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
22. Antiovulatory actions of RU 486: the pituitary is not the primary site of action in vivo.
Heikinheimo O; Gordon K; Lähteenmäki P; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1995 Jun; 80(6):1859-68. PubMed ID: 7775633
[TBL] [Abstract][Full Text] [Related]
23. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
Batista MC; Cartledge TP; Zellmer AW; Nieman LK; Merriam GR; Loriaux DL
J Clin Endocrinol Metab; 1992 Mar; 74(3):565-70. PubMed ID: 1740491
[TBL] [Abstract][Full Text] [Related]
24. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey.
Ghosh D; Nayak NR; Sengupta J
Contraception; 1997 Aug; 56(2):117-22. PubMed ID: 9315421
[TBL] [Abstract][Full Text] [Related]
25. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
26. Luteal contraception.
Yen S; Garzo G; Liu J
Contraception; 1987; 36 Suppl():13-25. PubMed ID: 2824125
[TBL] [Abstract][Full Text] [Related]
27. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
Remohi J; Balmaceda JP; Rojas FJ; Asch RH
Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
[TBL] [Abstract][Full Text] [Related]
28. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
29. Variations in plasma levels of substance P and effects of a specific substance P antagonist of the NK(1) receptor on preovulatory LH and FSH surges and progesterone secretion in the cycling cynomolgus monkey.
Kerdelhué B; Williams RF; Lenoir V; Fardin V; Kolm P; Hodgen GD; Jones GS; Scholler R; Jones HW
Neuroendocrinology; 2000 Apr; 71(4):228-36. PubMed ID: 10773742
[TBL] [Abstract][Full Text] [Related]
30. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
31. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
32. [Steroids and the prediction of ovulation].
Audebert AJ; Emperaire JC; Ruffie A
Contracept Fertil Sex (Paris); 1984 Feb; 12(2):411-9. PubMed ID: 12265829
[TBL] [Abstract][Full Text] [Related]
33. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
35. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
36. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
Shoupe D; Mishell DR; Page MA; Madkour H; Spitz IM; Lobo RA
Am J Obstet Gynecol; 1987 Dec; 157(6):1421-6. PubMed ID: 2827482
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
38. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
39. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
40. Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman.
Leyendecker G; Wildt L; Gips H; Nocke W; Plotz EJ
Arch Gynakol; 1976; 221(1):29-45. PubMed ID: 989265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
